Introduction {#s1}
============

The genus *Mycobacterium* contains many clinically relevant pathogens, including *Mycobacterium tuberculosis* and *Mycobacterium leprae*, the etiologic agents of tuberculosis (TB) and leprosy, respectively. *M. tuberculosis* alone was responsible for 8.7 million incident cases and 1.4 million deaths globally in 2011 [@pone.0079411-WHO1]. The treatment of TB has become increasingly difficult due to its high drug resistance and adaptability; hence, the development of new and more effective treatments for TB is imperative.

Bacterial "small RNAs" (sRNAs) are small (50--400 nt), typically untranslated transcripts. Many sRNAs play important roles in gene regulation in response to environmental changes [@pone.0079411-Gottesman1]. sRNAs can originate from their own independent genes or through the processing of larger transcripts [@pone.0079411-Vogel1]. To exert their function, sRNAs typically base-pair with target messenger RNAs (mRNAs), resulting in altered transcription, mRNA stability, or translation [@pone.0079411-Gottesman2]. sRNAs are key regulators of pathogenesis in many bacterial species [@pone.0079411-Papenfort1]. Recently, RNA-seq has been widely applied to identify novel sRNA candidates in many bacterial species [@pone.0079411-Shinhara1]--[@pone.0079411-Mitschke1], including *M. tuberculosis* [@pone.0079411-Arnvig1]. sRNAs have also been identified/predicted in *M. tuberculosis* using other experimental approaches [@pone.0079411-Arnvig2]--[@pone.0079411-Miotto1] and computational analysis of DNA sequence [@pone.0079411-DiChiara1], [@pone.0079411-Pellin1], [@pone.0079411-Pelly1]. In total, 63 sRNAs have been experimentally validated in *M. tuberculosis*. sRNAs have also been identified in other mycobacterial species: 34 and 15 sRNAs have been experimentally validated in *Mycobcaterium bovis* BCG and *Mycobacterium smegmatis*, respectively [@pone.0079411-DiChiara1].

In a previous study, we used computational predictions from the SIPHT ([s]{.ul}RNA [I]{.ul}dentification [P]{.ul}rotocol using [H]{.ul}igh-throughput [T]{.ul}echnologies) [@pone.0079411-Livny1] algorithm to identify 144 sRNA candidates in *M. bovis* BCG. We selected 34 conserved sRNA candidates which we experimentally confirmed by Northern blot [@pone.0079411-DiChiara1]. In the current study, we expanded our search to include all the remaining SIPHT predictions for *M. bovis* BCG as well as all SIPHT predictions for *M. smegmatis* (these were not explored in the previous study). By combining SIPHT predictions with large-scale Northern blot validation, we have identified 23 and 17 novel sRNAs in *M. bovis* BCG and *M. smegmatis*, respectively. Thus, we have substantially increased the number of experimentally validated sRNAs in mycobacterial species. We also analyzed existing ChIP-seq datasets to identify possible regulators of sRNA expression, and used Deep-RACE, a technique that combines high throughput RNA-seq with Rapid Amplification of cDNA Reads (RACE) [@pone.0079411-Beauregard1], to identify sRNA 5′ and 3′ ends. Lastly, it is worth noting that this work is one of the first efforts to better coordinate genome annotation; all sRNA candidates identified in this study have been renamed with a new nomenclature [@pone.0079411-Lamichhane1].

Materials and Methods {#s2}
=====================

Strains and Plasmids {#s2a}
--------------------

*M. bovis* BCG (Pasteur strain, Trudeau Institute), and *M. tuberculosis* H37Rv were grown in mycomedium (as previously reported, [@pone.0079411-DiChiara1]). *M. bovis* BCG and *M. tuberculosis* cultures were grown for 7 days, with shaking, to late-log phase. Cultures of *M. smegmatis* MC^2^155 were grown shaking at 37°C, in trypticase soy media supplemented with 0.05% Tween 80 for 18 hours with shaking (late-log phase).

Phylogenetic Selection of Computationally Predicted sRNA Candidates {#s2b}
-------------------------------------------------------------------

Small RNA candidates of *M. smegmatis* were predicted using the SIPHT program with the same parameters as described previously [@pone.0079411-Livny1], [@pone.0079411-Livny2]. SIPHT identifies potential sRNA candidates based on the presence of intergenic sequence conservation upstream of putative Rho-independent terminators. SIPHT has been widely applied in sRNA studies [@pone.0079411-Postic1]--[@pone.0079411-Xia1], and its reliability has been tested and compared with other algorithms [@pone.0079411-Lu1].

RNA Isolation and Northern Blot Analysis {#s2c}
----------------------------------------

RNA was isolated as previously reported [@pone.0079411-DiChiara1]. Northern blot analysis was performed as previously reported [@pone.0079411-DiChiara1]; probes were designed according to SIPHT predicted sequences and tested in *M. bovis* BCG, *M. smegmatis* and *M. tuberculosis* [@pone.0079411-DiChiara1]. All the oligonucleotides that were used in this study are listed in [Table S1](#pone.0079411.s005){ref-type="supplementary-material"}.

ChIP-seq Analysis {#s2d}
-----------------

We analyzed existing ChIP-seq datasets for 55 *M. tuberculosis* transcription factors extracted from a previous study [@pone.0079411-Galagan1]. ChIP-seq peak positions were compared to the 5′ end positions of *M. bovis* BCG and *M. tuberculosis* sRNAs from the current study and two previous studies [@pone.0079411-Arnvig2], [@pone.0079411-Pellin1]. For *M. bovis* BCG sRNAs, we first identified the equivalent region of the *M. tuberculosis* H37Rv genome. Possible sRNA regulators were selected if the ChIP-seq peak was located within 100 bp upstream and 20 bp downstream of an sRNA 5′ end.

Deep 5′ and 3′ RACE {#s2e}
-------------------

Deep 5′ RACE and Deep 3′ RACE were performed as previously described [@pone.0079411-Beauregard1] with the following exceptions. Deep 5′ RACE libraries and Deep 3′ RACE libraries were pooled and sequenced together using an Ion Torrent 316 chip (Wadsworth Center Applied Genomic Technologies Core Facility). For Deep 5′ RACE, sequence reads were identified by the presence of the expected adapter sequence at the read 5′ end. Adapter sequences were removed and reads of \>40 nt were mapped to the reference genomes using BWA [@pone.0079411-Li1]. For Deep 3′ RACE, sequence reads were identified by the presence of the expected adapter sequence. Adapter sequences were removed. The oligo-dT stretch was removed by identifying the first consecutive pair of bases not including a "T" and removing all sequence upstream of this. Sequences of \>40 nt were mapped to the reference genomes using BWA [@pone.0079411-Li1]. For both Deep 5′ RACE and Deep 3′ RACE, 5′ and 3′ ends were identified as the position with the most sequence reads, and with a minimum of 5 reads. Sequences of all primers used for Deep RACE are listed in [Table S2](#pone.0079411.s006){ref-type="supplementary-material"}.

Results and Discussion {#s3}
======================

Prediction of sRNAs in silico using SIPHT {#s3a}
-----------------------------------------

Using SIPHT, we identified 93 candidate sRNAs in *M. smegmatis* (refseq: NC_008596) ([Table S3](#pone.0079411.s007){ref-type="supplementary-material"}) and 144 candidate sRNAs in *M. bovis* BCG (refseq: NC_008769) ([Table S4](#pone.0079411.s008){ref-type="supplementary-material"}). [Tables S3](#pone.0079411.s007){ref-type="supplementary-material"} and [S4](#pone.0079411.s008){ref-type="supplementary-material"} include a detailed description of the predicted coordinates, orientations, sizes and neighboring upstream and downstream genes. Northern probes were designed according to SIPHT prediction. [Figure 1](#pone-0079411-g001){ref-type="fig"} summarizes the overall approach that was employed in this work for sRNA identification and confirmation.

![Schematic for sRNA identification.\
This schematic shows the combination of computational approaches and Northern blotting analysis used to identify the reported novel sRNAs in *M. bovis* BCG and *M. smegmatis*.](pone.0079411.g001){#pone-0079411-g001}

17 Novel sRNAs Identified in Mycobacterium Smegmatis {#s3b}
----------------------------------------------------

All 93 *M. smegmatis* sRNA candidates were tested by Northern blot using oligonucleotides in both orientations; expression was confirmed for 18 sRNA (listed in [Table 1](#pone-0079411-t001){ref-type="table"}; see blot pictures in [Figure 2](#pone-0079411-g002){ref-type="fig"} and [Figure S1](#pone.0079411.s001){ref-type="supplementary-material"}). One of them (Sm32/33) was identified in recent work as IGR-1 with similar size, coordinates and same orientation [@pone.0079411-Li2]. Thus, 17 *M. smegmatis* sRNAs identified here have not been experimentally demonstrated in any previous studies. In our previous study [@pone.0079411-DiChiara1], we reported homologs of 6 *M. smegmatis* sRNA candidates (Sm32/Sm33, Sm35, Sm46, Sm47, and Sm74) in *M. bovis* BCG (Mpr13/Mcr14, Mpr20, Mpr3, Mpr4, and Mpr5, respectively). These were confirmed directly in *M. smegmatis* by Northern blotting in current study and listed in the 17 novel confirmed sRNAs. A homologue of Sm76 was previously identified in *M. tuberculosis* by RNA-seq [@pone.0079411-Pellin1] and microarray analysis [@pone.0079411-Miotto1] but not otherwise experimentally confirmed. All of the validated sRNAs were in the same orientation to that predicted by SIPHT. This suggests that the sequence specificity of SIPHT for this prediction is higher than in our previous work, in which 9 out of 37 of the validated sRNAs were in the opposite orientation to the prediction [@pone.0079411-DiChiara1]. All confirmed sRNAs were assigned gene names according to a recently-proposed nomenclature [@pone.0079411-Lamichhane1].

![Northern blotting confirmation of sRNA candidates in *M.* smegmatis.\
Selected images of Northern blotting analysis for validated *M. smegmatis* sRNAs; the remaining images are included in [Figure S1](#pone.0079411.s001){ref-type="supplementary-material"}. Lane 1 and 2 indicate total RNA samples extracted from *M. smegmatis* and *M. bovis* BCG, respectively. We used Phi-X174/Hae III Marker for the size prediction. The probes we used for this analysis are listed in [Table S1](#pone.0079411.s005){ref-type="supplementary-material"}.](pone.0079411.g002){#pone-0079411-g002}

10.1371/journal.pone.0079411.t001

###### sRNAs confirmed by Northern blotting analysis in *M. smegmatis.*

![](pone.0079411.t001){#pone-0079411-t001-1}

                                                                                      Homology confirmed by Northern analysis in:                       
  ------------------------------------------ ----------------- --------------------- --------------------------------------------- --- ---------------- -------------------
  **Intergenic sRNAs**                                                                                                                                  
  Sm19                                        [5029661]{.ul}      [5029530]{.ul}                                                        ncMSMEG14931Ac       100--118
  Sm32/33[\#](#nt102){ref-type="table-fn"}     [417709]{.ul}       [417796]{.ul}                           ✓                            ncMSMEG10373A           44
  Sm35                                        [1458488]{.ul}      [1458562]{.ul}                           ✓                            ncMSMEG11363A           118
  Sm46                                        [5864890]{.ul}      [5864989]{.ul}                           ✓                            ncMSMEG15796A           82
  Sm49                                        [1086797]{.ul}      [1087035]{.ul}                                                        ncMSMEG11016A         48--66
  Sm64                                            2523008           **2522888**                            ✓                        ✓   ncMSMEG12439Ac       100--118
  Sm76                                          **3690377**         **3690280**                            ✓                        ✓   ncMSMEG13628Ac       100--118
  Sm82                                        4392939/4392970       **4393039**                            ✓                            ncMSMEG14302A       66/82--100
  **Total overlapping sense sRNAs**                                                                                                                     
  Sm38                                        [2236980]{.ul}      [2237466]{.ul}                           ✓                             ncMSMEG2161A      48--66/66--82
  Sm41                                        3815700/3815647       **3815581**                            ✓                            ncMSMEG3749Ac     48--66/100--118
  Sm90                                        [6845964]{.ul}      [6846035]{.ul}                           ✓                        ✓    ncMSMEG6799A         48--66
  Sm93                                          **858482**          **858588**                             ✓                             ncMSMEG0774A     66--82/100--118
  **Total overlapping antisense sRNAs**                                                                                                                 
  Sm42                                        4290417/4290487       **4290537**                            ✓                        ✓    ncMSMEG4206A     48--66/100--118
  Sm67                                        2600405/2600425       **2600485**                                                          ncMSMEG2514A      48--66/66--82
  Sm68                                        [2600389]{.ul}      [2600701]{.ul}                                                         ncMSMEG2514B         82--100
  Sm74                                        [3111233]{.ul}      [3111268]{.ul}                           ✓                             ncMSMEG3037A         66--82
  **Partial overlapping antisense sRNAs**                                                                                                               
  Sm11                                            2835860       **2835984/2835999**                        ✓                            ncMSMEG12771A    100--118/140--151
  **Not categorized sRNAs**                                                                                                                             
  Sm47                                        [6242319]{.ul}      [6242668]{.ul}                           ✓                            ncMSMEG16173A           311

The coordinates in bold were determined by 5′ or 3′ Deep-RACE. Where only one end was determined by Deep RACE, the other end was estimated based on the size determined by Northern blot. Where neither end was determined by Deep RACE, SIPHT-predicted coordinates are listed (underlined text).

Experimentally demonstrated in previous study [@pone.0079411-Li2].

Given the practical convenience of testing RNA from both species simultaneously to search for novel sRNA candidates, we used the designed probes for sRNA detection in *M. smegmatis* to also probe expression of these candidates in *M. bovis* BCG and *M. tuberculosis*. Although our focus was to validate *M. smegmatis* predictions, we fortuitously discovered homologues of 9 candidates in *M. bovis* BCG and 4 candidates in *M. tuberculosis* ([Table 1](#pone-0079411-t001){ref-type="table"}, [Figure S2](#pone.0079411.s002){ref-type="supplementary-material"}). Since these probes were not specifically designed for the other two species, lack of detection could be due to either the absence of sRNA expression or to non-optimization of the probe sequence that was used for hybridization to the targeted region in the *M. bovis* BCG and *M. tuberculosis* genome. Also, differences in culture medium might contribute to the low number of expressed homologous sRNAs of *M. smegmatis* in *M. tuberculosis* as expression of these sRNAs could be specific to different conditions in *M. tuberculosis*. Given our focus in sRNA identification, specific conditions that could lead to differences in sRNA expression will be explored in future work.

23 Novel sRNAs Identified in Mycobacterium Bovis BCG {#s3c}
----------------------------------------------------

Twenty-one of the sRNA candidates for *M. bovis* BCG (Bo12, Bo15, Bo41, Bo52, Bo58, Bo67, Bo68, Bo75, Bo80, Bo85, Bo99, Bo100, Bo111, Bo113, Bo115, Bo117, Bo122, Bo125, Bo126, Bo137, and Bo139) were previously identified, under the nomenclature Mpr 1--21, respectively [@pone.0079411-DiChiara1]. Forty-six other candidates were also tested previously but showed no signal; therefore, only the remaining 77 candidates were tested using Northern blotting analysis in this study, and we confirmed expression of 23 new sRNA candidates ([Figure 3](#pone-0079411-g003){ref-type="fig"} and [Figure S3](#pone.0079411.s003){ref-type="supplementary-material"}). A homologue of Bo46 was previously identified in *M. tuberculosis* by RNA-seq [@pone.0079411-Pellin1] but not otherwise experimentally validated. All of the validated sRNAs were in the same orientation as that predicted by SIPHT. We also applied the probes to *M. smegmatis* and *M. tuberculosis* and identified 20 and 5 sRNA homologues, respectively ([Table 2](#pone-0079411-t002){ref-type="table"}; [Figure 3](#pone-0079411-g003){ref-type="fig"}; [Figure S3](#pone.0079411.s003){ref-type="supplementary-material"}). All the confirmed sRNAs in *M. bovis* BCG and *M. tuberculosis* are listed in [Table 2](#pone-0079411-t002){ref-type="table"}, along with the new nomenclature for sRNAs.

![Northern blotting confirmation of sRNA candidates in *M. bovis* BCG.\
Selected images of Northern blotting analysis for validated *M. bovis* BCG sRNAs; the remaining images are included in [Figure S2](#pone.0079411.s002){ref-type="supplementary-material"}. Lane 1 and 2 indicate total RNA samples extracted from *M. bovis* BCG and *M. smegmatis*, respectively. We used Phi-X174/Hae III Marker for the size prediction. The probes we used for this analysis are listed in [Table S1](#pone.0079411.s005){ref-type="supplementary-material"}.](pone.0079411.g003){#pone-0079411-g003}

10.1371/journal.pone.0079411.t002

###### sRNAs confirmed by Northern blotting analysis in *M. Bovis* BCG.

![](pone.0079411.t002){#pone-0079411-t002-2}

                                                                                                 Homology confirmed by Northern analysis in:                     
  ----------------------------------------- --------------------- ----------------------------- --------------------------------------------- --- -------------- ------------------
  **Intergenic sRNAs**                                                                                                                                           
  Bo35                                           **576179**             **576067/576104**                             ✓                            ncBCG10493Ac    48--66/82--100
  Bo48                                             3028936                 **3028876**                                ✓                        ✓   ncBCG12782Ac        48--66
  Bo53                                             1044606         **1044706/1044720/1044727**                        ✓                            ncBCG10960A    82--100/100--118
  Bo60                                             1247638                 **1247538**                                ✓                            ncBCG11150Ac        66/100
  Bo71                                         [1588853]{.ul}            [1588693]{.ul}                               ✓                        ✓   ncBCG11448Ac          66
  Bo73                                         [1647817]{.ul}            [1647853]{.ul}                               ✓                            ncBCG11504A         66--82
  Bo78                                           **207337**                **207179**                                 ✓                        ✓   ncBCG10186Ac        66/100
  Bo86                                         [2325795]{.ul}            [2325960]{.ul}                               ✓                            ncBCG12107A         66--82
  Bo101                                            2919337                 **2919277**                                ✓                            ncBCG2654Ac         48--66
  Bo118                                            3765977                 **3765917**                                ✓                            ncBCG13438Ac        48--66
  Bo132                                            4260533                 **4260610**                                ✓                            ncBCG13885A         66--82
  Bo105                                        [3073445]{.ul}            [3073541]{.ul}                                                            ncBCG12831A         66--82
  **Partial overlapping sense sRNAs**                                                                                                                            
  Bo27                                           **2157804**                 2157704                                  ✓                            ncBCG11948Ac       82--100
  Bo46                                             2603016                 **2602916**                                ✓                        ✓   ncBCG12368Ac         100
  Bo82                                             2235286                 **2235196**                                ✓                            ncBCG12024Ac       82--100
  Bo87                                       **2351000/2351046**       **2350915/2350874**                            ✓                        ✓   ncBCG12128Ac   48--66/66--82/82
  **Partial overlapping antisense sRNAs**                                                                                                                        
  Bo32                                           **817571**                **817483**                                 ✓                            ncBCG10734Ac      66--82/82
  Bo47                                       **2705925/2705838**           **2705735**                                                             ncBCG12462Ac       82--100
  Bo81                                             218700                  **2187796**                                ✓                            ncBCG10195A         66/100
  Bo96                                           **2686849**             2686909/2686989                              ✓                            ncBCG12441A    66--82/118--142
  Bo130                                         [413416]{.ul}             [413288]{.ul}                               ✓                            ncBCG0352Ac    66--82/118--142
  **Not categorized sRNAs**                                                                                                                                      
  Bo13                                         [3126934]{.ul}            [3127070]{.ul}                                                            ncBCG12882A     48--66/82--100
  Bo29                                         [1770012]{.ul}            [1769806]{.ul}                               ✓                            ncBCG11603Ac        66--82

The coordinates in bold were determined by 5′ or 3′ Deep-RACE. Where only one end was determined by Deep RACE, the other end was estimated based on the size determined by Northern blot. Where neither end was determined by Deep RACE, SIPHT-predicted coordinates are listed (underlined text).

Deep-RACE Identifies sRNA 5′ and 3′ Ends {#s3d}
----------------------------------------

We used Deep-RACE, a previously described approach that combines conventional RACE and deep sequencing to identify 5′ and 3′ ends of selected RNAs [@pone.0079411-Beauregard1], [@pone.0079411-Olivarius1]. In total, we identified 5′ ends for 9 sRNAs and 3′ ends for 21 sRNAs. Examples are shown in [Figure 4](#pone-0079411-g004){ref-type="fig"}. For some sRNAs we identified multiple 5′/3′ ends. Multiple 5′ ends could be due to multiple transcription start sites or RNA processing. Multiple 3′ ends could be due to RNA processing or may indicate imprecise Rho-dependent termination of transcription.

![Identification of sRNA 5′ and 3′ ends by Deep RACE.\
Blue lines show the number of 5′ RACE reads mapped to respective genome, while red lines show the number of 3′ RACE reads. The coordinates with the highest number of mapped reads (the peak) indicate the likely 5′ and 3′ ends of sRNAs and are labeled in the figure. The orange arrow under the chart shows where the Northern probes base-paired and the blue arrows are the adjacent annotated coding regions. Results for other sRNAs can be found in [Figure S4](#pone.0079411.s004){ref-type="supplementary-material"}.](pone.0079411.g004){#pone-0079411-g004}

Size Comparisons between Experimental and Prediction Analysis {#s3e}
-------------------------------------------------------------

As noted in our earlier study [@pone.0079411-DiChiara1], the predicted size of the candidate sRNAs correlates only weakly with experimental observations. Only about 17% of the confirmed sRNAs were within 10% of their predicted sizes. Additionally, in many cases, multiple bands were detected by Northern analysis, suggesting the presence of multiple start sites, multiple termination sites, and/or sRNA processing. This is consistent with the Deep RACE data ([Figure 4](#pone-0079411-g004){ref-type="fig"}; [Figure S4](#pone.0079411.s004){ref-type="supplementary-material"}). Deep RACE identified both 5′ and 3′ ends for seven sRNAs. In these cases, the sizes determined by Deep RACE are similar to those confirmed by Northern blotting.

Location of sRNAs with Respect to Genes {#s3f}
---------------------------------------

To investigate the potential roles of the novel sRNAs, we mapped them all to the latest annotated genome (National Center for Biotechnology Information, NCBI). Although we aimed to find intergenic sRNAs, half of the candidates we identified in this study overlap partially or entirely protein-coding genes in either the sense or antisense orientation ([Table 1](#pone-0079411-t001){ref-type="table"}, [Table 2](#pone-0079411-t002){ref-type="table"}). We categorized sRNAs into different classes according to their position relative to adjacent coding regions. Where possible, we used 5′/3′ end information from Deep-RACE data. For sRNAs that have only one end mapped by Deep-RACE, the other end was estimated according to the length confirmed by Northern blotting analysis ([Figure 4](#pone-0079411-g004){ref-type="fig"}). For sRNAs that have neither end mapped by Deep-RACE, the farthest possible ends were estimated according to Northern blotting analysis and the sRNAs would be categorized as "not determined" if multiple class options exist.

Nine sRNAs in *M. smegmatis* (Sm19, Sm32/33, Sm35, Sm46, Sm49, Sm64, Sm76, Sm82) and twelve sRNAs in *M. bovis* BCG (Bo35, Bo48, Bo53, Bo60, Bo71, Bo73, Bo78, Bo86, Bo101, B0105, Bo118, Bo132) were mapped completely to intergenic regions. Four sRNAs in *M. smegmatis* (Sm38, Sm41, Sm90, Sm93) were mapped to the sense strand of annotated protein-coding genes, and four were mapped to the antisense strand (Sm42, Sm67, Sm68, Sm74). One sRNA in *M. smegmatis* (Sm11) and five in *M. bovis* BCG (Bo32, Bo47, Bo81, Bo96, Bo130) overlap partially with adjacent genes in the antisense orientation, and four sRNAs in *M. bovis* BCG (Bo27, Bo46, Bo82, Bo87) overlap partially with adjacent genes in the sense orientation. One sRNA in *M. smegmatis* (Sm47) and two in *M. bovis* BCG (Bo13, Bo29) were not classified.

The location of sRNAs relative to protein-coding genes also gives clues as to their function. Regulatory sRNAs that are completely intergenic typically function by base-pairing with distally-encoded mRNAs; however, some of the sRNAs are close to the 5′ end or 3′ end of adjacent genes, suggesting possible alternative regulatory roles. sRNAs antisense to ORFs or UTRs can regulate expression of the overlapping gene [@pone.0079411-Georg1]. sRNAs located within UTRs or ORFs in the sense orientation may be degradation products or mRNAs or could be important *cis*-acting regulatory elements such as riboswitches.

sRNAs can be transcribed independently or generated by processing of mRNA UTRs. Several features of the sRNAs identified in this work are consistent with the sRNAs being independently transcribed from their own promoters. First, the Northern blots showed no evidence of larger bands that could correspond to pre-processed mRNAs. Second, 13 sRNAs (Sm35, Sm42, Sm67, Sm68, Sm74, Bo13, Bo32, Bo60, Bo71, Bo73, Bo81, Bo118, Bo130) are orientated away from the surrounding genes. Third, 5 sRNAs (Sm64, Sm82, Bo47, Bo105, Bo132) are located \>200 bp from the nearest gene start/stop. Nineteen sRNAs are close to (\<200 bp) upstream or downstream coding regions (Sm11, Sm19, Sm32/33, Sm46, Sm47, Sm49, Sm76, Bo27, Bo29, Bo35, Bo46, Bo48, Bo53, Bo78, Bo82, Bo86, Bo87, Bo96, Bo101) and four (Sm38, Sm41, Sm90, Sm93) overlap coding regions in the sense orientation. It is formally possible that these sRNAs are generated by mRNA processing or premature termination, although the Northern blot analysis argues against this. Regardless, sRNAs processed from mRNAs could still have important regulatory functions [@pone.0079411-Vogel1], [@pone.0079411-Kawano1], [@pone.0079411-Loh1]. Indeed, a recent study identified 3′ UTRs as an abundant source of regulatory sRNAs in *Salmonella enterica* [@pone.0079411-Chao1]. Alternatively, sRNAs generated by processing of mRNAs could indicate *cis*-acting regulatory elements such as riboswitches.

Likely Regulators of sRNAs Identified by Analysis of ChIP-seq Datasets {#s3g}
----------------------------------------------------------------------

The regulation of sRNAs can provide important clues as to their biological functions. However, very little is currently known about regulation of mycobacterial sRNAs. The genome-wide binding profiles of many *M. tuberculosis* transcription factors have recently been determined using ChIP-seq and these data are publicly available [@pone.0079411-Galagan1]. Although we identified sRNAs in *M. bovis* BCG, it is highly likely that these sRNAs are conserved in *M. tuberculosis* given the extremely high similarity of the *M. bovis* BCG and *M. tuberculosis* genomes [@pone.0079411-Garnier1]. Hence, we searched existing ChIP-seq datasets of *M. tuberculosis* for transcription factors that bind close to sRNA 5′ ends, including sRNAs identified in earlier studies [@pone.0079411-Arnvig2]. We identified 10 ChIP-seq peaks (indicative of a transcription factor binding site) located between 100 bp upstream and 20 bp downstream of sRNA 5′ ends ([Table S5](#pone.0079411.s009){ref-type="supplementary-material"}). Thus, we have identified likely examples of sRNA regulation. In some cases, the ChIP-seq peak is also close to the start of an annotated protein-coding gene. Hence, the transcription factor may regulate the protein-coding gene rather than the sRNA. Nevertheless, in four cases, the ChIP-seq peak is unambiguously associated with an sRNA 5′ end. The two examples with highest ChIP-seq signal are shown in [Figure 5](#pone-0079411-g005){ref-type="fig"}. For each of these examples, the transcription factor is otherwise uncharacterized.

![ChIP-seq peaks associated with predicted sRNA homologues in *M. tuberculosis*.\
ChIP-seq peaks that are unambiguously associated with sRNA 5′ ends. Raw ChIP-seq data from [www.tbdb.org](http://www.tbdb.org) are shown for two transcription factors, (A) Rv2887, and (B) Rv3249c. Data are shown for genomic regions surrounding (A) sRNA Bo132 (this work), and (B) sRNA B55 [@pone.0079411-Arnvig2]. The green and blue graphs indicate the relative number of sequence reads mapping to the plus and minus strands, respectively. The yellow graphs indicate the sum of plus and minus strand reads. Annotated genes are shown as gray arrows. sRNAs are shown as red triangles.](pone.0079411.g005){#pone-0079411-g005}

Conclusion {#s4}
==========

In summary, we have identified 17 novel sRNAs in *M. smegmatis* and 23 novel sRNAs in *M. bovis* BCG, verified 5′ and 3′ ends, and list these sRNAs according to a recently-proposed annotation nomenclature. Our analysis of sRNA position relative to protein-coding genes suggests various potential roles for these sRNAs in gene regulation. Although the specific biological function of these, and all other known mycobacterial sRNAs, is not understood, we speculate that some of these sRNAs contribute to the biology of pathogenic mycobacterial species. Future studies will focus on the functional characterization of these novel sRNAs.
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